Maternal treatments with a mitochondrial antioxidant prevents alterations in transcriptional regulators of metabolic and antioxidant responses in embryos from diabetic rats

. ROMINA HIGA, SABRINA ROBERTI, MARIA BELEN MAZZUCCO, ALICIA JAWERBAUM

Mar del Plata

Congreso; VI SLIMP Latin American Symposium on Maternal Fetal Interaction and Placenta; 2015

SLIMP

Maternal diabetes induces an increase in embryo malformations and oxidative stress has been suggested to have a teratogenic role. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor that activates antioxidant cellular response. The transcriptional coactivator PPARã coactivator-1á (PGC-1á) is a master regulator of cellular energy that can regulate mitochondrial function and biogenesis. Idebenone is an antioxidant acting as a transporter in the electron transport chain of mitochondria . Aims: To analyze the effect of idebenone administration to control and diabetic pregnant rats on TNFá, NRF2 and PGC-1á expression and peroxynitrite-induced damage in embryos during early organogenesis. Methods: Diabetes was induced by neonatal streptozotocin administration (90 mg/kg). Adult control and diabetic female rats were mated with healthy males. Pregnant rats were treated with idebenone (100 mg/kg) or vehicle from days 0.5 to 10.5 of pregnancy. Embryonic expression of TNFá, NRF2 and PGC-1á was measured by PCR and nitrotyrosine levels, which indicate peroxynitrite-induced damage, by immunohistochemistry. Results: We found increased expression of TNFá (p